Literature DB >> 12074707

CTL: Caspases Terminate Life, but that's not the whole story.

N J Waterhouse1, J A Trapani.   

Abstract

The induction of cell death by cytotoxic T-lymphocytes (CTL) or natural killer (NK) cells is one of the main ways by which higher organisms protect themselves from rogue cells, including those infected by a virus, or posing a risk of cancer. Considering the rapidity of viral replication and spread to uninfected cells, CTL and NK are extremely efficient killers. This is at least partly due to the variety of pathways that these cytolytic lymphocytes (CL) can use to ensure the death of a cell. Primarily, CL utilize two independently initiated pathways involving either ligation of death receptors or perforin mediated trafficking of granzyme B to the target cell cytosol to activate a family of death proteases (caspases) in the target cell. The caspases then orchestrate the orderly dismantling of that cell by cleavage of a set of critical substrates. If caspases are inactivated, due either to mutations in proteins that signal their activation or direct inhibition by a viral gene product, CL can utilize a caspase-independent pathway to ensure the death of the target cell. Here we will discuss the mechanisms by which these stellar killers achieve their goal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074707     DOI: 10.1034/j.1399-0039.2002.590301.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

Review 1.  Combining radiotherapy and immunotherapy: a revived partnership.

Authors:  Sandra Demaria; Nina Bhardwaj; William H McBride; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

2.  Evidence for the existence of granzyme-like serine proteases in teleost cytotoxic cells.

Authors:  Kesavannair Praveen; Donald L Evans; Liliana Jaso-Friedmann
Journal:  J Mol Evol       Date:  2004-04       Impact factor: 2.395

3.  Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.

Authors:  German G Gomez; Susana B Read; Lazaro E Gerschenson; Daniela Santoli; Adam Zweifach; Carol A Kruse
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

4.  Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.

Authors:  Christina Lönnroth; Marianne Andersson; Annette Arvidsson; Svante Nordgren; Hans Brevinge; Kristina Lagerstedt; Kent Lundholm
Journal:  Cancer Immun       Date:  2008-02-29

5.  Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737.

Authors:  V R Sutton; K Sedelies; G Dewson; M E Christensen; P I Bird; R W Johnstone; R M Kluck; J A Trapani; N J Waterhouse
Journal:  Cell Death Dis       Date:  2012-07-05       Impact factor: 8.469

6.  Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis.

Authors:  Nigel J Waterhouse; Vivien R Sutton; Karin A Sedelies; Annette Ciccone; Misty Jenkins; Stephen J Turner; Phillip I Bird; Joseph A Trapani
Journal:  J Cell Biol       Date:  2006-04-10       Impact factor: 10.539

7.  Granzyme B; the chalk-mark of a cytotoxic lymphocyte.

Authors:  Nigel J Waterhouse; Karin A Sedelies; Chris Jp Clarke
Journal:  J Transl Med       Date:  2004-10-25       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.